Bahcall, Magda <br/><br/>
Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung Cancer.  [electronic resource] 

 -  Cancer discovery  12 2016 
 - 1334-1341 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>2159-8290 
<br/><br/><label>Standard No.: </label>10.1158/2159-8290.CD-16-0686  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adenocarcinoma of Lung<br/>Anilides--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Drug Resistance, Neoplasm<br/>ErbB Receptors--genetics<br/>Erlotinib Hydrochloride--therapeutic use<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Mutation<br/>Protein Kinase Inhibitors--therapeutic use<br/>Proto-Oncogene Proteins c-met--genetics<br/>Pyridines--therapeutic use<br/>Treatment Outcome